DOI:
10.1055/s-00000085
The Thoracic and Cardiovascular Surgeon
LinksClose Window
References
Judson I, Verweij J, Gelderblom H. et al; European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Lancet Oncol 2014;
15 (04) 415-423
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.